This book provides an evidence-based approach for the clinical use of nutraceuticals in the prevention and management of cardiovascular disease. It examines cardiovascular disease epidemiology, risk factors, and the role of dietary patterns. Clinical chapters discuss the use of nutraceuticals in the management of medical conditions such as dyslipidemia, hypertension, insulin resistance, and heart failure. Each chapter contains a short epidemiological background; a list of relevant active compounds and their efficacy, tolerability, and safety; and suggestions for prescribers. This book is a…mehr
This book provides an evidence-based approach for the clinical use of nutraceuticals in the prevention and management of cardiovascular disease. It examines cardiovascular disease epidemiology, risk factors, and the role of dietary patterns. Clinical chapters discuss the use of nutraceuticals in the management of medical conditions such as dyslipidemia, hypertension, insulin resistance, and heart failure. Each chapter contains a short epidemiological background; a list of relevant active compounds and their efficacy, tolerability, and safety; and suggestions for prescribers. This book is a practical guide with the best clinical evidence supporting the use of nutraceuticals in cardiology.
Nutraceuticals and Cardiovascular Disease: An Evidence-based Approach for Clinical Practice is an essential resource for physicians, residents, fellows, and medical students in cardiology, clinical nutrition, dietetics, and internal medicine.
Arrigo F.G. Cicero, MD, PhD President of the Italian Nutraceutical Society (SINut) Associate Professor of Dietary Sciences Dept. of Medical and Surgical Sciences Alma Mater Studiorum University of Bologna Italy Prof. Manfredi Rizzo, MD, PhD Associate Professor of Internal Medicine Department of Health Promotion Sciences Maternal and Infantile Care, Internal Medicine and Medical Specialties (PROMISE) School of Medicine University of Palermo Italy
Inhaltsangabe
Chapter 1. Introduction to Cardiovascular Disease Epidemiology and Risk Factors.- Chapter 2. Definition of Nutraceuticals (Both Scientific and Legal).- Chapter 3. Evidence-based Approach to Nutraceuticals in Cardiovascular Medicine.- Chapter 4. Dietary Patterns and Cardiovascular Disease Risk: From Epidemiology to Intervention.- Chapter 5. Single Dietary Components and Cardiovascular Disease Risk: From Epidemiology to Intervention.- Chapter 6. Nutraceuticals for Dyslipidemia Management.- Chapter 7. Nutraceuticals for Hypertension Management.- Chapter 8. Nutraceuticals for Management of Insulin Resistance.- Chapter 9. Nutraceuticals Supporting Body Weight Loss.- Chapter 10. Nutraceuticals for Non-alcoholic Fatty Liver Disease Management.- Chapter 11. Nutraceuticals for Homocysteine Reduction.- Chapter 12. Nutraceuticals Supporting Cognitive Function in Mild Cognitive Impairment.- Chapter 13. Nutraceuticals Supporting Heart Function in Heart Failure.- Chapter 14. Nutraceuticals with Potential Adverse Cardiovascular Events or Pharmacological Interaction with Cardiometabolic Drugs.
Chapter 1. Introduction to Cardiovascular Disease Epidemiology and Risk Factors.- Chapter 2. Definition of Nutraceuticals (Both Scientific and Legal).- Chapter 3. Evidence-based Approach to Nutraceuticals in Cardiovascular Medicine.- Chapter 4. Dietary Patterns and Cardiovascular Disease Risk: From Epidemiology to Intervention.- Chapter 5. Single Dietary Components and Cardiovascular Disease Risk: From Epidemiology to Intervention.- Chapter 6. Nutraceuticals for Dyslipidemia Management.- Chapter 7. Nutraceuticals for Hypertension Management.- Chapter 8. Nutraceuticals for Management of Insulin Resistance.- Chapter 9. Nutraceuticals Supporting Body Weight Loss.- Chapter 10. Nutraceuticals for Non-alcoholic Fatty Liver Disease Management.- Chapter 11. Nutraceuticals for Homocysteine Reduction.- Chapter 12. Nutraceuticals Supporting Cognitive Function in Mild Cognitive Impairment.- Chapter 13. Nutraceuticals Supporting Heart Function in Heart Failure.- Chapter 14. Nutraceuticals with Potential Adverse Cardiovascular Events or Pharmacological Interaction with Cardiometabolic Drugs.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497